{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T11:40:30Z","timestamp":1649072430213},"reference-count":15,"publisher":"Sociedade Portuguesa de Estomatologia e Medicina Dentaria (SPEMD)","issue":"2","license":[{"start":{"date-parts":[[2010,4,1]],"date-time":"2010-04-01T00:00:00Z","timestamp":1270080000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,12,2]],"date-time":"2014-12-02T00:00:00Z","timestamp":1417478400000},"content-version":"vor","delay-in-days":1706,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Revista Portuguesa de Estomatologia, Medicina Dent\u00e1ria e Cirurgia Maxilofacial"],"published-print":{"date-parts":[[2010,4]]},"DOI":"10.1016\/s1646-2890(10)70093-5","type":"journal-article","created":{"date-parts":[[2012,6,29]],"date-time":"2012-06-29T14:00:37Z","timestamp":1340978437000},"page":"95-101","source":"Crossref","is-referenced-by-count":1,"title":["Osteonecrose dos Maxilares Associada ao Uso de Bifosfonatos. Parte I: Etiologia e Apresenta\u00e7\u00e3o Cl\u00ednica"],"prefix":"10.24873","volume":"51","author":[{"given":"Ana Isabel","family":"Coelho","sequence":"first","affiliation":[]},{"given":"Pedro de Sousa","family":"Gomes","sequence":"additional","affiliation":[]},{"given":"Maria Helena","family":"Fernandes","sequence":"additional","affiliation":[]}],"member":"10497","reference":[{"key":"10.1016\/S1646-2890(10)70093-5_bib1","series-title":"Bisphosphonates in Medical Practice: Actions, Side Effects, Indications, Strategies","author":"Bartl","year":"2007"},{"key":"10.1016\/S1646-2890(10)70093-5_bib2","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/S0278-2391(03)00720-1","article-title":"Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic","volume":"61","author":"Marx","year":"2003","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/S1646-2890(10)70093-5_bib3","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.joms.2004.02.004","article-title":"Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases","volume":"62","author":"Ruggiero","year":"2004","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/S1646-2890(10)70093-5_bib4","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/j.1601-0825.2007.01381.x","article-title":"Updates on bisphosphonates and potential pathobiology of bisphosphonate-induced jaw osteonecrosis","volume":"14","author":"Sarin","year":"2008","journal-title":"Oral Dis"},{"key":"10.1016\/S1646-2890(10)70093-5_bib5","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1146\/annurev.med.60.063007.134350","article-title":"Bisphosphonate-related osteonecrosis of the jaw: diagnosis, prevention, and management","volume":"60","author":"Ruggiero","year":"2009","journal-title":"Annu Rev Med"},{"issue":"5 Suppl","key":"10.1016\/S1646-2890(10)70093-5_bib6","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.joms.2008.10.005","article-title":"Bisphosphonate-related osteonecrosis of the jaw (BRONJ): initial discovery and subsequent development","volume":"67","author":"Ruggiero","year":"2009","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/S1646-2890(10)70093-5_bib7","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.oraloncology.2009.01.002","article-title":"Osteonecrosis of the jaws in patients treated with intravenous bisphosphonates (BRONJ): A concise update","volume":"45","author":"Bagan","year":"2009","journal-title":"Oral Oncol"},{"key":"10.1016\/S1646-2890(10)70093-5_bib8","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1200\/JOP.2.1.7","article-title":"Practical Guidelines for the Prevention, Diagnosis, and Treatment of Osteonecrosis of the Jaw in Patients With Cancer","volume":"2","author":"Ruggiero","year":"2006","journal-title":"J Oncol Prac"},{"key":"10.1016\/S1646-2890(10)70093-5_bib9","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1359\/jbmr.0707onj","article-title":"Bisphosphonate-associated osteonecrosis of the jaw: report of a task force of the American Society for Bone and Mineral Research","volume":"22","author":"Khosla","year":"2007","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S1646-2890(10)70093-5_bib10","first-page":"1391","article-title":"Canadian consensus practice guidelines for bisphosphonate associated osteonecrosis of the jaw","volume":"35","author":"Khan","year":"2008","journal-title":"J Rheumatol"},{"key":"10.1016\/S1646-2890(10)70093-5_bib11","series-title":"Dental Management of Patients Receiving Oral Bisphosphonate Therapy - Expert Panel Recommendations. Report of the Council on Scientific Affairs","author":"Association","year":"2008"},{"issue":"12 Suppl","key":"10.1016\/S1646-2890(10)70093-5_bib12","doi-asserted-by":"crossref","first-page":"2961","DOI":"10.1002\/1097-0142(20000615)88:12+<2961::AID-CNCR12>3.0.CO;2-L","article-title":"Cellular and molecular mechanisms of action of bisphosphonates","volume":"88","author":"Rogers","year":"2000","journal-title":"Cancer"},{"key":"10.1016\/S1646-2890(10)70093-5_bib13","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1124\/jpet.102.035295","article-title":"Novel antiangiogenic effects of the bisphosphonate compound zoledronic acid","volume":"302","author":"Wood","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"issue":"5 Suppl","key":"10.1016\/S1646-2890(10)70093-5_bib14","first-page":"2","article-title":"American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws--2009 update","volume":"67","author":"Ruggiero","year":"2009","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/S1646-2890(10)70093-5_bib15","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1111\/j.1601-0825.2009.01568.x","article-title":"Bisphosphonate-related osteonecrosis: genetic and acquired risk factors","volume":"15","author":"Sarasquete","year":"2009","journal-title":"Oral Dis"}],"container-title":["Revista Portuguesa de Estomatologia, Medicina Dent\u00e1ria e Cirurgia Maxilofacial"],"original-title":[],"language":"pt","link":[{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S1646289010700935?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S1646289010700935?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1646289010700935","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,9,21]],"date-time":"2017-09-21T05:44:17Z","timestamp":1505972657000},"score":1,"resource":{"primary":{"URL":"http:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1646289010700935"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4]]},"references-count":15,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,4]]}},"alternative-id":["S1646289010700935"],"URL":"https:\/\/doi.org\/10.1016\/s1646-2890(10)70093-5","relation":{},"ISSN":["1646-2890"],"issn-type":[{"value":"1646-2890","type":"print"}],"subject":[],"published":{"date-parts":[[2010,4]]}}}